Nike's Running Revival Alters The Narrative Around The Stock

Nike Running grew more than 20% in the latest quarter, marking a second consecutive quarter of 20%+ growth and providing early evidence that the company’s new sports offense is working. The article contrasts this strength with ongoing headwinds, including low-double-digit declines in Sportswear, a 10% revenue drop in Greater China, and more than $4 billion of revenue pressure from traditional footwear lines. Overall, the piece is constructive on Nike’s turnaround, but still cautious on timing and broader execution risk.

Analysis

The market is treating Nike like a broken cyclical, but the running franchise suggests the business is more likely in a selective re-acceleration phase than a broad deterioration. The important second-order effect is channel leverage: if a hero performance category can sustain >20% growth while the company rationalizes legacy demand, wholesale partners and full-price sell-through should see less promotional pressure than the market assumes, which supports gross margin stabilization over the next 2-3 quarters.

The real signal is not category growth itself; it is that the new operating model is proving repeatable in a high-visibility sport with strong athlete-led demand. That matters because running is usually the cleanest read-through for product innovation, and if the playbook is working there, it can be transplanted into footwear-adjacent categories with lower execution risk than investors fear. The upside case is not a V-shaped rebound in the next month, but a step-function improvement in confidence over 2-4 quarters as the Street begins to underwrite broader portfolio turnarounds.

The main risk is that investors over-extrapolate from one pocket of strength while the rest of the portfolio remains in digestion mode. Sportswear and China can offset running for several quarters, so the stock can stay cheap longer than bulls expect; that keeps timing risk high even if the strategic thesis is right. A second-order bear case is that running’s success pulls mix toward premium product but not enough volume to absorb the $4B+ revenue reset, leaving earnings power structurally lower than prior peaks.

Consensus appears to be pricing Nike as a slow-bleed turnaround with no clear catalyst; what it may be missing is that the first credible proof point of the new operating model is already visible in the one category where brand heat and product cadence matter most. That makes the setup asymmetric: limited near-term multiple expansion if the market insists on proof, but meaningful rerating potential if another category follows within the next two earnings prints.

Key Decisions for Investors

• Initiate a tactical long in NKE over the next 1-2 weeks, targeting a 3-6 month horizon; use a starter position only, because the upside is multiple expansion if the running-led narrative broadens, while the downside is contained by already-depressed expectations.
• Buy NKE call spreads 4-6 months out to express a limited-risk view that the market re-prices the turnaround before the next two earnings cycles; structure strikes around a move back toward the midpoint of its historical P/S range.
• Pair trade: long NKE / short a basket of lower-quality apparel or footwear peers with weaker innovation cadence and higher promotional exposure; the spread benefits if investors rotate toward brands showing real product momentum.
• Do not short NKE here unless China data re-accelerates negatively or running growth decelerates below high-teens in the next quarter; the asymmetry is poor for outright shorts because the catalyst path is skewed toward gradual confirmation, not immediate reversal.
• Set a catalyst watchlist for the next earnings print and wholesale channel commentary; if another major sport shows even mid-teens growth, add to NKE aggressively because that would validate the playbook and extend the rerating window by several quarters.